- Telehealth Visits
- Insurance plan information
Laura Schoenherr, MD
- Telehealth Visits
- Insurance plan information
Laura Schoenherr, MD
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Laura Schoenherr is a palliative care physician who treats patients with serious illness. She helps improve their quality of life through symptom management, advance care planning, and emotional as well as social support.
Schoenherr earned her medical degree from UCSF, where she also completed a residency in internal medicine and a fellowship in hospice and palliative medicine.
Schoenherr is a member of the American Academy of Hospice and Palliative Medicine.
In her free time, Schoenherr enjoys travel, yoga, going on walks with her dog and spending time with her family.
Education & training
Board certification
- Hospice & Palliative Medicine, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Palliative Medicine, UCSF Graduate Medical Education
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, UCSF School of Medicine
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.